GCIA
CDIOW icon

Gabelli & Co Investment Advisers’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,410
Closed -$1.11K – 248
2022
Q4 		$1.11K Hold
22,410
– – ﹤0.01% 271
2022
Q3 		$3K Hold
22,410
– – ﹤0.01% 400
2022
Q2 		$4K Sell
22,410
-590
-3% -$115 ﹤0.01% 431
2022
Q1 		$5K Buy
+23,000
New +$5.46K ﹤0.01% 490

Other funds holding CDIOW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.61% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Gabelli & Co Investment Advisers's CDIOW Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q1 2023, closing a stake of 22,410 shares — an estimated $1.11K sold.

Gabelli & Co Investment Advisers first reported a position in CDIOW in Q1 2022 and held it in 4 quarters. The position peaked at $5K in Q1 2022. 16 funds tracked by Wall St. Rank hold CDIOW as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 22,410 Cardio Diagnostics Holdings Inc Warrant shares in Q1 2023, an estimated $1.11K.
  • Gabelli & Co Investment Advisers first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 4 quarters.
  • Gabelli & Co Investment Advisers's Cardio Diagnostics Holdings Inc Warrant position peaked at $5K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.